Email this article Polymorphism of Matrix Metalloproteinases Genes MMP1, MMP2, MMP3, and MMP7 and the Risk of Varicose Veins of Lower Extremities
- Authors: Shadrina A.S.1, Smetanina M.A.1, Sevost’yanova K.S.1, Shevela A.I.1, Seliverstov E.I.2, Zakharova E.A.2, Voronina E.N.1, Ilyukhin E.A.3, Zolotukhin I.A.2, Kirienko A.I.2, Filipenko M.L.1
-
Affiliations:
- Institute of Chemical Biology and Fundamental Medicine, Siberian Division of the Russian Academy of Sciences
- N. I. Pirogov Russian National Research Medical University, Ministry of the Health of the Russian Federation
- Medalp Clinic
- Issue: Vol 163, No 5 (2017)
- Pages: 650-654
- Section: Article
- URL: https://journals.rcsi.science/0007-4888/article/view/239162
- DOI: https://doi.org/10.1007/s10517-017-3871-2
- ID: 239162
Cite item
Open Access
Access granted
Subscription Access
Abstract
We studied the effects of single nucleotide polymorphisms in the promoter regions of matrix metalloproteinase genes rs1799750 (-1607dupG) MMP1, rs243865 (C-1306T) MMP2, rs3025058 (-1171dupA) MMP3, and rs11568818 (A-181G) MMP7 on the risk of varicose vein of the lower extremities in ethnical Russians, residents of the Russian Federation. We genotyped 536 patients with this pathology and 273 healthy participants without history of chronic venous disease. Association was examined using logistic regression analysis. None of the studied polymorphisms showed statistically significant association with the risk of varicose veins of the lower extremities. Our results provide evidence that these polymorphisms are not involved in the pathogenesis of varicose veins and cannot serve as markers of predisposition to this pathology.
About the authors
A. S. Shadrina
Institute of Chemical Biology and Fundamental Medicine, Siberian Division of the Russian Academy of Sciences
Author for correspondence.
Email: weiner.alexserg@gmail.com
Russian Federation, Novosibirsk
M. A. Smetanina
Institute of Chemical Biology and Fundamental Medicine, Siberian Division of the Russian Academy of Sciences
Email: weiner.alexserg@gmail.com
Russian Federation, Novosibirsk
K. S. Sevost’yanova
Institute of Chemical Biology and Fundamental Medicine, Siberian Division of the Russian Academy of Sciences
Email: weiner.alexserg@gmail.com
Russian Federation, Novosibirsk
A. I. Shevela
Institute of Chemical Biology and Fundamental Medicine, Siberian Division of the Russian Academy of Sciences
Email: weiner.alexserg@gmail.com
Russian Federation, Novosibirsk
E. I. Seliverstov
N. I. Pirogov Russian National Research Medical University, Ministry of the Health of the Russian Federation
Email: weiner.alexserg@gmail.com
Russian Federation, Moscow
E. A. Zakharova
N. I. Pirogov Russian National Research Medical University, Ministry of the Health of the Russian Federation
Email: weiner.alexserg@gmail.com
Russian Federation, Moscow
E. N. Voronina
Institute of Chemical Biology and Fundamental Medicine, Siberian Division of the Russian Academy of Sciences
Email: weiner.alexserg@gmail.com
Russian Federation, Novosibirsk
E. A. Ilyukhin
Medalp Clinic
Email: weiner.alexserg@gmail.com
Russian Federation, St. Petersburg
I. A. Zolotukhin
N. I. Pirogov Russian National Research Medical University, Ministry of the Health of the Russian Federation
Email: weiner.alexserg@gmail.com
Russian Federation, Moscow
A. I. Kirienko
N. I. Pirogov Russian National Research Medical University, Ministry of the Health of the Russian Federation
Email: weiner.alexserg@gmail.com
Russian Federation, Moscow
M. L. Filipenko
Institute of Chemical Biology and Fundamental Medicine, Siberian Division of the Russian Academy of Sciences
Email: weiner.alexserg@gmail.com
Russian Federation, Novosibirsk
